Genomics The Future of Biotechnology: 4 Stocks to Watch – CMC Markets
Disclaimer Past performance is not a reliable indicator of future results.
CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general...
Cellect Biotechnology Stock: Surviving, Not Thriving – Nanalyze
Fear of missing out, FOMO, is the bane of every newbie investor who sees rapid short-term price appreciation as a good thing. When a stock doubles in a single trading session, that’s the type...
Study finds a restricted number of possible escape mutations for SARS-CoV-2 Delta variant
The emergence of escape mutations in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is somewhat less likely for the Delta variant in comparison with the original or wild type virus, shows a recent...
Simple and rapid method measures T-cell immune response to SARS-CoV-2 virus
Researchers from Duke-NUS Medical School, together with collaborators from the National Centre for Infectious Diseases (NCID) and Singapore General Hospital (SGH), have discovered a simple and rapid method to measure the T-cell immune response...
UTSA receives $3.2 million CPRIT grant for developing new approach to fight against cancer
The University of Texas at San Antonio (UTSA) has been awarded a five-year $3.2 million grant from the Cancer Prevention & Research Institute of Texas (CPRIT). The money will go toward work at The...
European biotechnology video & product of the week campaign Sep 2021 – European Biotechnology...
Ihr Browser unterstützt leider kein JavaScript. Ohne JavaScript können diese Seiten nicht ordentlich...
Curative Biotechnology, Inc. Announces Addition of Dr. Nicholas – GlobeNewswire
Company's Clinical Program for CD56 Monoclonal Antibody Drug Conjugate for Treatment of Glioblastoma to Benefit from Expertise in Neurobiology Boca Raton, FL, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUBT), announced...
Running Up That Hill: Nessan Bermingham on Close to the Edge
Bermingham has enjoyed a front-row seat for the conception and launch of several dynamic biotech companies. Perhaps the best known is Intellia Therapeutics, one of the first wave of public CRISPR gene editing companies....
Discovery of Triplet Stabilizing Factor Fans Hope for Huntington’s and Other Repeat Expansion Disorders
When CAG nucleotide triplets repeat excessively in a gene called huntingtin, a devastating and currently untreatable neurodegenerative “repeat expansion disorder” arises called Huntington’s Disease (HD).
New research from groups at the University College of London...
CRISPR-Engineered Cells Release Drug in Response to Inflammation When Implanted into Mice
Researchers at Washington University School of Medicine in St. Louis have used CRISPR-Cas9 genome editing to engineer induced pluripotent stem cells (iPSCs) that can be implanted subcutaneously to deliver an anticytokine biologic drug in...
